Richard J. Daly
At a glance: Richard J. Daly is Director at Aquestive Therapeutics (AQST). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $4K. On file: 2 purchase lines ($99K) and 0 sale lines ($0).
Disclosed holdings: about $110K of AQST stock: 28,025 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $3.91. This counts only AQST shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Aquestive Therapeutics, Inc. (AQST)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | AQSTAquestive Therapeutics, Inc.First buyNew position | Buy | 1,200new position | $3.53 | $4K | +10.8% |
| Nov 12SEC | AQSTAquestive Therapeutics, Inc.First buyStake +2,235% | Buy | 26,82528,025 held (+2235%) | $3.54 | $95K | +10.3% |
- Buy
Director Richard J Daly bought $4K of AQST at $3.53 — first open-market purchase in our records; opens a new position.
- Buy
Director Richard J Daly bought $95K of AQST at $3.54 — largest purchase by this insider in our records; raises the stake by 2235%.
Follow Richard J. Daly
Get one email when Richard J. Daly files a new purchase or sale. Free.
At most one email a day about Richard J. Daly, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.